Background The onset of disease in ankylosing spondylitis (AS) is generally earlier than in
other joint diseases, exposing patients to a prolonged burden of disease. Whether this is …

Objective To estimate the prevalence of rheumatoid arthritis (RA) from international
population-based studies and investigate the influence of prevalence definition, data sources, …

Objective. Rituximab (RTX) is an anti-CD20 antibody used successfully in granulomatosis with
polyangiitis (GPA) for induction and maintenance of remission. Our study aims to evaluate …

OBJECTIVE: Anemia of chronic disease (ACD) is the most common extraarticular
manifestation of rheumatoid arthritis (RA), but there is limited information on the cause and …

… Black MBBS, FRACP b c f , Johannes C. Nossent MD, PhD d f , Carlee Ruediger BHSc (Hon),
PhD a b f , Leanne Nguyen MBBS (student) b f , Jem V. Ninan MBBS, MD, FRACP b e f , …

Objective. Rituximab (RTX) is a B cell depleting agent used to induce and maintain
remission in patients with granulomatosis with polyangiitis (GPA). As the development of …

Objective. Cytokines are central regulators of the immune response but the workings of this
complex network in systemic lupus erythematosus (SLE) are not fully understood. We …

OBJECTIVE: To describe the course of disease activity and determine predictors of remission
and relapse in a population based cohort of patients with Wegener's granulomatosis (WG). …

… Nossent has received speaking fees (less than $10,000 each) from Abbott Norway and …
Address correspondence to Johannes C. Nossent, MD, PhD, Department of Rheumatology, …

Introduction With scarce comparative data on mortality in Australian patients with rheumatoid
arthritis (RA), we investigated temporal changes in standardized mortality rates for patients …